Key Points Androgens are the main driver of prostate cancer growth, and androgen signalling often leads to castration-resistant prostate cancer (CRPC), which can continue to progress despite androgen-deprivation therapy (ADT) Glucocorticoids have long been included in the treatment and management of patients with prostate cancer
The manufacturers of both drugs also offer savings programs and patient assistance programs for people who qualify
However, interactions can still occur, particularly with Tranexamic Acid, which has antifibrinolytic properties
Growth factors like epidermal growth factor (EGF) are also produced by trophoblasts to induce their invasion, differentiation, and proliferation (45)
Poor sleep can disrupt these processes and increase oxidative stress
Curiously, CT2 that, in normal conditions, has a very narrow and specific tissue distribution, becomes widely expressed in cancers even originating from tissues in which CT2 is normally not present, further highlighting the carnitine role in human cancers